Results 231 to 240 of about 2,529,224 (293)

Enhanced ovarian cancer diagnosis using deep learning on pelvic ultrasound with integrated clinical data: retrospective multicenter study. [PDF]

J Gynecol Oncol
Jeong S, Cho H, Kim J, Lee S, Song JY, Hong JH, Lee JK, Kim SK, Cho HW.   +8 more
europepmc   +1 more source

Primary Mammary Angiosarcoma in a Postmenopausal Woman: A Case Report. [PDF]

Cancer Rep (Hoboken)
Liu T, Xu Y, Wang Q, Yu S, Lin H, Ye Z, Zheng Z, Yang C, Hong T.   +8 more
europepmc   +1 more source

Comparison of Frozen Section and Final Pathology Results in Borderline Ovarian Tumors: A Retrospective Cohort Study. [PDF]

Diagnostics (Basel)
Sozen I, Baba ZF, Aksoy I, Topal GNE, Sahin G, Yuksel IT.   +5 more
europepmc   +1 more source

Application of Serum CA125, HE4, ROMA, and CPH-I in the Preoperative Differentiation of Ovarian Tumors: A Diagnostic Accuracy Study. [PDF]

J Clin Lab Anal
Feng W, Zhang C, Meng L, Chen Y, Yu H, Zhai Y, Cao Z.   +6 more
europepmc   +1 more source

Outcomes of refractory and early‐relapsed large B‐cell lymphoma patients after first‐line treatment in the prospective Real‐world dAta in LYmphoma patients and Survival in Adults (REALYSA) cohort in the pre‐CAR T era

British Journal of Haematology, EarlyView.
Stéphanie Guidez, Aurélien Belot, Fanny Cherblanc, Bastien Lesné, Sylvain Carras, Catherine Thieblemont, Fontanet Bijou, Cédric Rossi, Luc Mathieu Fornecker, Jehan Dupuis, Krimo Bouabdallah, Ludovic Fouillet, Adrien Chauchet, Benoit Tessoulin, Loic Ysebaert, Alice Pauc, Pascale Cony‐Makhoul, Remy Gressin, Gaelle Laboure, Antoine Bonnet, Sandy Amorim, Christophe Fruchart, Roch Houot, Gian Matteo Pica, Carole Soussain, Sophie Dennetiere, Cécile Leyronnas, Pauline Lionne‐Huyghe, Hervé Ghesquières, Pierre Sesques   +29 more
wiley   +1 more source

The CA 125 tumour-associated antigen: a review of the literature

Human Reproduction, 1989
CA 125 is an antigenic determinant on a high-molecular-weight glycoprotein recognized by a monoclonal antibody which was raised using an ovarian cancer cell line as an immunogen. During the last 5 years the studies reviewed in this paper have provided information concerning the nature, distribution and clinical significance of CA 125.
Jacobs, I., Bast, R. C.
core   +14 more sources

Some of the next articles are maybe not open access.

Related searches:

CA 125 Antigen Is an Effective Diagnostic for External Endometriosis

Gynecologic and Obstetric Investigation, 2010
We measured serum levels of CA 125 in 26 patients with external endometriosis, using CA 125 RIA Kits. The normal range was instituted below 39 U/ml. The mean CA 125 level ( ± SD) was 55.1 ± 24.9 U/ml in patients with external endometriosis, the positive rate being 71.4%.
K, Takahashi, Y, Yamane, S, Kijima, K, Yoshino, T, Shibukawa, M, Kitao   +5 more
openaire   +2 more sources

Tumour‐associated antigen CA 125 in patients with ovarian cancer

BJOG: An International Journal of Obstetrics & Gynaecology, 1985
Summary. The serum levels of antigen CA 125 expressed by epithelial ovarian carcinoma were measured in 27 postmenopausal women with ovarian tumours and in 16 controls. Increased serum levels of CA 125 were found in nine (75%) out of 12 patients with ovarian cancer; in three with stage I disease levels were not elevated.
P K, Heinonen, K, Tontti, T, Koivula, P, Pystynen   +3 more
openaire   +2 more sources